These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7433486)

  • 1. Reward system depression following chronic amphetamine: antagonism by haloperidol.
    Barrett RJ; White DK
    Pharmacol Biochem Behav; 1980 Oct; 13(4):555-9. PubMed ID: 7433486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic basis for the facilitation of brain stimulation reward by the NMDA receptor antagonist, MK-801.
    Olds ME
    Eur J Pharmacol; 1996 Jun; 306(1-3):23-32. PubMed ID: 8813611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A progressive ratio schedule of self-stimulation testing in rats reveals profound augmentation of d-amphetamine reward by food restriction but no effect of a "sensitizing" regimen of d-amphetamine.
    Cabeza de Vaca S; Krahne LL; Carr KD
    Psychopharmacology (Berl); 2004 Aug; 175(1):106-13. PubMed ID: 14985931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term influence of d-amphetamine on mesolimbic brain-stimulation reward: comparison to chronic haloperidol and naloxone effects.
    Borowski TB; Kokkinidis L
    Pharmacol Biochem Behav; 1992 Sep; 43(1):1-15. PubMed ID: 1409792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catecholamines and endogenous opioids in ventral tegmental self-stimulation reward.
    van Wolfswinkel L; Seifert WF; van Ree JM
    Pharmacol Biochem Behav; 1988 Jul; 30(3):589-95. PubMed ID: 3211968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects on hypothalamic self-stimulation of drugs influencing dopaminergic neurotransmission injected into nucleus accumbens and corpus striatum of rats.
    Stephens DN; Herberg LJ
    Psychopharmacology (Berl); 1977 Aug; 54(1):81-5. PubMed ID: 198840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dopamine supersensitivity on lateral hypothalamic self-stimulation in rats.
    Ettenberg A; Milner PM
    Pharmacol Biochem Behav; 1977 Dec; 7(6):507-14. PubMed ID: 563603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of reward and aversion processes in the rat diencephalon by neuroleptics: differential effects of clozapine and haloperidol.
    Atrens DM; Ljungberg T; Ungerstedt U
    Psychopharmacology (Berl); 1976 Aug; 49(1):97-100. PubMed ID: 822454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of amphetamine isomers and neuroleptics on self-stimulation from the nucleus accumbens and dorsal noradrenergic bundle.
    Phillips AG; Brooke SM; Fibiger HC
    Brain Res; 1975 Feb; 85(1):13-22. PubMed ID: 1109690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actions and interactions of amphetamine on self-stimulation in rats.
    Aulakh CS; Pradhan SN
    Pharmacol Biochem Behav; 1979 Sep; 11(3):351-4. PubMed ID: 41267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catecholaminergic mechanisms of the lateral hypothalamus: their role in the mediation of amphetamine anorexia.
    Leibowitz SF
    Brain Res; 1975 Nov; 98(3):529-45. PubMed ID: 1182535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotine and brain-stimulation reward: interactions with morphine, amphetamine and pimozide.
    Huston-Lyons D; Sarkar M; Kornetsky C
    Pharmacol Biochem Behav; 1993 Oct; 46(2):453-7. PubMed ID: 8265701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reward summation and the effects of dopamine D1 and D2 agonists and antagonists on fixed-interval responding for brain stimulation.
    Hunt GE; Atrens DM; Jackson DM
    Pharmacol Biochem Behav; 1994 Aug; 48(4):853-62. PubMed ID: 7972288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed D2/5-HT2A antagonism of amphetamine-induced facilitation of brain stimulation reward.
    Frank RA; Tsibulsky V; Grocki S; Dashevsky B; Kehne JH; Schmidt CJ; Sorensen SM
    Pharmacol Biochem Behav; 1995 Dec; 52(4):799-804. PubMed ID: 8587922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of the rewarding effect of brain stimulation by a blockade of dopamine D1 receptor with SCH 23390.
    Nakajima S; McKenzie GM
    Pharmacol Biochem Behav; 1986 Apr; 24(4):919-23. PubMed ID: 3520603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous rate-independent and rate-dependent assessment of intracranial self-stimulation: evidence for the direct involvement of dopamine in brain reinforcement mechanisms.
    Zarevics P; Setler PE
    Brain Res; 1979 Jun; 169(3):499-512. PubMed ID: 312681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic l-dopa fails to lessen rebound enhancement of self-stimulation after chronic haloperidol.
    Rose IC; Mintz M; Herberg LJ
    Pharmacol Biochem Behav; 1988 Jul; 30(3):585-8. PubMed ID: 3211967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The melanocortin receptor agonist MTII augments the rewarding effect of amphetamine in ad-libitum-fed and food-restricted rats.
    Cabeza de Vaca S; Kim GY; Carr KD
    Psychopharmacology (Berl); 2002 Apr; 161(1):77-85. PubMed ID: 11967634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaco-ontogeny of reward: enhancement of self-stimulation by D-amphetamine and cocaine in 3- and 10-day-old rats.
    Barr GA; Lithgow T
    Brain Res; 1986 Jan; 389(1-2):193-202. PubMed ID: 3948007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of 5-HT2a receptors reduces haloperidol-induced attenuation of reward.
    Benaliouad F; Kapur S; Rompré PP
    Neuropsychopharmacology; 2007 Mar; 32(3):551-61. PubMed ID: 16794561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.